RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors

Not Applicable

Completed

Conditions: Survivorship
Fatigue

Interventions: Behavioral: Exercise Intervention
Behavioral: Internet-Based Intervention
Device: Monitoring Device
Other: Quality-of-Life Assessment

First Posted Date: 2016-02-23

Last Posted Date: 2021-04-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 49

Registration Number: NCT02688192

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Optimizing Clinical Use of Polymyxin B

Completed

Conditions: Pneumonia
Respiratory Tract Infection (Including Tracheobronchitis)
Sepsis
Blood Stream Infection
Urinary Tract Infections

First Posted Date: 2016-02-15

Last Posted Date: 2024-12-02

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 155

Registration Number: NCT02682355

Locations: 🇧🇷
Hospital Sao Lucas da - PUC / RS, Porto Alegre, Brazil
🇸🇬
Singapore General Hospital, Singapore, Singapore
🇺🇸
Columbia University Medical Center, New York, New York, United States

and more 3 locations

Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

Phase 2

Active, not recruiting

Conditions: Autism
Autistic Disorder
Autism Spectrum Disorder
Autistic Behavior

Interventions: Drug: Placebo
Drug: Sulforaphane

First Posted Date: 2016-02-09

Last Posted Date: 2024-11-18

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 48

Registration Number: NCT02677051

Locations: 🇺🇸
Rutgers University - Staged Research Building, Piscataway, New Jersey, United States

Air Pollution Study: The Effect of Ozone on the Lung

Not Applicable

Completed

Conditions: Air Pollution

Interventions: Other: Clean Air
Other: Ozone

First Posted Date: 2016-02-04

Last Posted Date: 2023-10-11

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 135

Registration Number: NCT02673775

Locations: 🇺🇸
Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, United States

Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures

Phase 3

Completed

Conditions: Blood Coagulation Disorders
Hemorrhage

Interventions: Biological: Fresh frozen plasma transfusion

First Posted Date: 2015-12-22

Last Posted Date: 2021-08-18

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 57

Registration Number: NCT02637427

Locations: 🇺🇸
Johns Hopkins University, The Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Not Applicable

Completed

Conditions: Liver Failure
Carcinoma, Hepatocellular

Interventions: Procedure: Remote Ischemic Conditioning (RIC)
Device: Pneumatic tourniquet

First Posted Date: 2015-12-18

Last Posted Date: 2019-08-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 31

Registration Number: NCT02635347

Locations: 🇺🇸
Rutgers University - University Hospital, Newark, New Jersey, United States

Improve Hypertension Monitoring and Self-management by Using mHealth

Not Applicable

Completed

Conditions: Hypertension

Interventions: Device: iHealth BP7-Wireless Blood Pressure Wrist Monitor,

First Posted Date: 2015-12-17

Last Posted Date: 2018-06-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 30

Registration Number: NCT02632838

Locations: 🇺🇸
Peijia Zha, Newark, New Jersey, United States

Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

Phase 1

Active, not recruiting

Conditions: Stage II Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer

Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy
Drug: Carboplatin
Radiation: Intensity-Modulated Radiation Therapy
Other: Laboratory Biomarker Analysis
Drug: Paclitaxel
Biological: Pembrolizumab

First Posted Date: 2015-12-03

Last Posted Date: 2023-12-14

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 23

Registration Number: NCT02621398

Locations: 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger

Not Applicable

Completed

Conditions: Substance Use Disorder

Interventions: Behavioral: Resonance Breathing
Behavioral: Non-Resonance Breathing

First Posted Date: 2015-10-19

Last Posted Date: 2022-03-28

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 107

Registration Number: NCT02579317

Locations: 🇺🇸
Center of Alcohol Studies, Piscataway, New Jersey, United States

Understanding the Role of the Anesthesiologist

Completed

Conditions: Preoperative Anxiety

First Posted Date: 2015-10-02

Last Posted Date: 2016-08-12

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 200

Registration Number: NCT02566642

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy